Document is current

Article History

Received: 22 July 2024

Accepted: 1 April 2025

First Online: 23 April 2025

Declarations

:

: Human endometrial tissue was obtained from agreeable donors with the approval of the Ethical Review Committee of Beijing Obstetrics and Gynecology Hospital (Title of the approved project: Studies on the functional mechanism of long noncoding RNA in IUA; Approval number:2022-KY-056-01; Date of approval: June 16th 2022). All contributors signed informed consents for voluntary donation of endometrial tissue at the Beijing Obstetrics and Gynecology Hospital. All animal experiments were approved by the animal ethics committee of Capital Medical University. (Title of the approved project: An exploratory study of immunity-and-matrix-regulatory cells for the treatment of IUA; Approval number: AEEI-2023-201; Date of approval: August 28th 2023). All experimental procedures will strictly comply with the requirements of the Ethics Committee and the Laboratory Animal Welfare Committee. The human umbilical cord mesenchymal stem cells used in this study were provided by Wuhan Pricella Biotechnology Co., Ltd. According to the source provider’s confirmation, the acquisition of human cell samples by the company was approved by their institutional ethics review committee, and written informed consent was obtained from all cell donors, explicitly agreeing to the use of their biological samples for scientific research.

: Not applicable.

: The authors declare that there are no conflicts of interest regarding the publication of this paper.

: Not applicable.